This is a remarkable moment for psychedelics. Elite universities, including Johns Hopkins and Imperial College in London, have opened centers to research the medical benefits of such drugs as psilocybin, a hallucinogen found in certain mushrooms. The nonprofit Multidisciplinary Association for Psychedelic Research (MAPS) is recruiting people suffering from PTSD to participate in FDA-approved clinical trials using MDMA, better known as molly or ecstasy. CBS News’ 60 Minutes last fall reported on life-changing psychedelic journeys.
So far, the psychedelic renaissance has focused on the potential of these dugs to heal mental illness, and rightly so. A growing body of research suggests that they can alleviate suffering caused by a broad array of ailments: depression, addiction and anxiety, among others. Philanthropy is critical to sustain progress because there’s almost no government money for research and scant interest from private industry.
This story, though, is not about how psychedelics can heal the mind. It’s about how they can heal the world. There is sickness all around us. The threat of climate change. Unconscionable poverty amidst great wealth. Extreme political polarization. These are manifestations of deeper ills: People feel disconnected from one another and from nature.
Serious people — not just hippies, but neuroscientists with PhDs, and their philanthropic supporters — say psychedelics can help address these deeper problems. Drug trips, under controlled conditions, break down the barriers between people and bring users closer to nature.
“These medicines can help us wake up to new levels of caring and concern,” says David Bronner, a philanthropist and the CEO of Dr. Bronner’s, the family-owned maker of natural soaps. “It’s crucial to wake up to the miraculous world we’re part of and understand how we can serve and make it better for all of us.”
You can read the rest of the story on Medium.